title: Should more patients with acute ischaemic stroke receive thrombolytic treatment?
authors.affiliation: Division of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU. joanna.wardlaw@ed.ac.uk
authors.forename: Joanna M
authors.initials: JM
authors.lastname: Wardlaw
authors.forename: Peter A G
authors.initials: PA
authors.lastname: Sandercock
authors.forename: Veronica
authors.initials: V
authors.lastname: Murray
mesh_terms: D035843:Biomedical Research; D002545:Brain Ischemia / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D055502:Secondary Prevention; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000706:statistics & numerical data; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator